Chemo (Various combination protocols (FOLFOX, CAPOX, others))

Other Medications

US FDA Approved IV 6 Clinical Trials

Description

"Chemo" appears to be a general reference to chemotherapy regimens used in colorectal cancer treatment, most commonly referring to combination protocols containing oxaliplatin and 5-fluorouracil (5-FU). These cytotoxic chemotherapy combinations serve as the backbone of both neoadjuvant and adjuvant treatment for colorectal cancer. Based on the clinical trial context, this likely represents standard chemotherapy protocols such as FOLFOX (5-FU, leucovorin, oxaliplatin) or CAPOX (capecitabine, oxaliplatin) used in multimodal treatment approaches.

Mechanism of Action

These chemotherapy combinations work through complementary cytotoxic mechanisms targeting rapidly dividing cancer cells. 5-fluorouracil functions as an antimetabolite, inhibiting thymidylate synthase and disrupting DNA synthesis, while oxaliplatin forms platinum-DNA crosslinks that prevent DNA replication and transcription. The combination creates synergistic anti-tumor effects by attacking multiple cellular processes essential for cancer cell survival and proliferation.

Side Effects

Peripheral neuropathy Nausea and vomiting Diarrhea Neutropenia Fatigue Mucositis Hand-foot syndrome Thrombocytopenia

Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.

Clinical Trials

NCT07448077 Phase 2
Recruiting
Short-course Radiotherapy in TNT Combined With Enlonstobart for pMMR LARC
China
NCT06758830 Phase 2
Recruiting
Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.
Lithuania
NCT02178644 Phase 1
Archived
Pilot Trial of KD018 With Neo-Adjuvant Concurrent Chemo-Radiation Therapy in Patients With Locally Advanced Rectal Cancer
United States
NCT02031939 Phase 3
Unknown
Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
China
NCT02709811 Phase 1
Archived
Safety and Feasibility of Electrochemotherapy in Unresectable Colorectal Adenocarninoma Liver Metastases
NCT00278694 Phase 2
Archived
Oxaliplatin and 5-FU Based Preoperative Chemoradiation
Norway